Inequities in Screening Between Black and White Adolescents in a Large Pediatric Primary Care Network, 2015-2019.

Am J Public Health

Sarah Wood and Danielle Petsis are with the PolicyLab and Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA. Jungwon Min and Vicky Tam are with the Department of Biostatistics and Health Informatics, Children's Hospital of Philadelphia. Julia Pickel is with the Wake Forest School of Medicine, Winston-Salem, NC. Kenisha Campbell is with the Craig-Dalsimer Division of Adolescent Medicine, Children's Hospital of Philadelphia.

Published: January 2022

To identify associations between patient race and annual chlamydia screening among adolescent females. We performed a retrospective cohort study of females aged 15 to 19 years in a 31-clinic pediatric primary care network in Pennsylvania and New Jersey from 2015 through 2019. Using mixed-effect logistic regressions, we estimated associations between annual chlamydia screening and patient (race/ethnicity, age, previous chlamydia screening and infection, insurance type) and clinic (size, setting) characteristics. We decomposed potential effects of clinician's implicit racial bias and screening, using covariates measuring the proportion of Black patients in each clinician's practice. There were 68 935 well visits among 37 817 females, who were 28.8% Black and 25.8% Medicaid insured. The mean annual chlamydia screening rate was 11.1%. Black females had higher odds of screening (adjusted odds ratio [AOR] = 1.67; 95% confidence interval [CI] = 1.51, 1.84) than did White females. In the clinician characteristics model, individual clinicians were more likely to screen their Black versus non-Black patients (AOR = 1.88; 95% CI = 1.65, 2.15). Racial bias may affect screening practices and should be addressed in future interventions, given the critical need to increase population-level chlamydia screening.(. 2022;112(1):135-143. https://doi.org/10.2105/AJPH.2021.306498).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713640PMC
http://dx.doi.org/10.2105/AJPH.2021.306498DOI Listing

Publication Analysis

Top Keywords

chlamydia screening
20
annual chlamydia
12
pediatric primary
8
primary care
8
care network
8
screening
8
racial bias
8
black
5
chlamydia
5
females
5

Similar Publications

Whole-genome automated assembly pipeline for strains from reference, and clinical samples using the integrated CtGAP pipeline.

NAR Genom Bioinform

March 2025

Departments of Medicine and Pediatrics, Division of Infectious Diseases and Global Health, University of California San Francisco School of Medicine, 550 16th Street, 4th Floor Mission Hall, San Francisco, CA, 94158, USA.

Whole genome sequencing (WGS) is pivotal for the molecular characterization of ()-the leading bacterial cause of sexually transmitted infections and infectious blindness worldwide. WGS can inform epidemiologic, public health and outbreak investigations of these human-restricted pathogens. However, challenges persist in generating high-quality genomes for downstream analyses given its obligate intracellular nature and difficulty with propagation.

View Article and Find Full Text PDF

Sexually transmitted proctitis, a prevalent concern among men who have sex with men (MSM) is frequently caused by a range of pathogens, including herpes simplex virus (HSV), and While HSV-associated proctitis typically presents with visible lesions, cases without external manifestations remain evasive. We report the case of an MSM in his early 30s presenting with dyschezia and perineal discomfort after unprotected anoreceptive intercourse. Despite initial inconspicuous findings, rectal swabs revealed HSV-2 infection.

View Article and Find Full Text PDF

The development of rapid and multiplexed point-of-care (POC) diagnostic tools is vital for the prevention and control of sexually transmitted diseases (STIs). Here, we developed a POC-comprehensive Thermococcus thioreducensArgonaute (TtrAgo)-mediated nucleic acid detection system (POC-CANDY) and palm-sized portable detection device "Owl-1" for the simultaneous detection of Ureaplasma urealyticum, Chlamydia trachomatis, Neisseria gonorrhoeae, human papillomavirus types 16/18 and antibiotic resistance molecular markers [tetM, and gyrA mutation (S91F)]. Using recombinase polymerase amplification (RPA), the optimized POC-CANDY could finish the whole detection procedure within 55 min and achieve a limit of detection of 10 copies/μL.

View Article and Find Full Text PDF

Introduction: Different species affect cattle and contribute to economic losses. One of them, , is a globally endemic livestock pathogen. Despite its endemicity, prevalence data from Poland have so far been limited.

View Article and Find Full Text PDF

Community pharmacies: Key players in point-of-care diagnostics for STI screening in Africa.

PLoS One

January 2025

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.

Background: Sexually Transmitted Infections (STIs) rank in the top 5 disease categories for which adults in developing countries seek healthcare services. Community pharmacies offer clients convenience, proximity, extended opening hours, privacy, and efficiency, which could make them desirable locations for HIV and STI screening and treatment. We examined the feasibility of using point-of-care (POC) STI tests for screening HIV and other STIs at community pharmacies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!